The Trump administration tapped Sara Brenner, a career FDA official, to serve as the acting commissioner of the agency.
Brenner’s selection to lead the Food and Drug Administration was posted Friday on the agency’s leadership web page. Her role comes as the agency awaits Senate confirmation nomination of President Donald Trump’s pick for agency commissioner, Johns Hopkins surgeon Marty Makary.
Brenner served as the chief medical officer for in vitro diagnostics at the FDA’s Center for Devices and Radiological Health, where she advised leadership on regulatory premarket and post-market compliance and surveillance, as well as broader initiatives ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.